Moderna Inc. logo

Moderna Inc.

MRNA | NASDAQ
Chart Builder DCF Calculator
$172.94
+$18.90 (+12.27%)
At close: Sep 21, 2026, 4:00 PM ET
$169.25
-$3.69 (-2.13%)
Pre-market: Sep 22, 2026, 8:18 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Revenue
1.94B 3.2B 6.85B 18.88B 17.74B 803.4M
Cost of Revenue
868M 1.46B 4.69B 5.42B 2.62B 39.18M
Gross Profit
1.08B 1.74B 2.16B 13.46B 15.12B 764.21M
Operating Income
-3.07B -3.95B -4.24B 9.42B 13.3B -763.14M
Interest Income
314M 425M 421M 200M 18M 24.72M
Pretax Income
-2.77B -3.61B -3.94B 9.58B 13.29B -744.51M
Net Income
-2.82B -3.56B -4.71B 8.36B 12.2B -747.06M
Selling & General & Admin
1.02B 1.17B 1.55B 1.13B 567M 188.27M
Research & Development
3.13B 4.54B 4.85B 3.3B 1.99B 1.37B
Other Expenses
n/a -37M n/a -388M -735M -31.25M
Operating Expenses
4.15B 5.68B 6.39B 4.04B 1.82B 1.53B
Interest Expense
10M 24M 38M 29M 18M 9.89M
Selling & Marketing Expenses
n/a 146M 204M 121M n/a n/a
Cost & Expenses
5.02B 7.14B 11.09B 9.46B 4.44B 1.57B
Income Tax Expense
54M -46M 772M 1.21B 1.08B 2.55M
Shares Outstanding (Basic)
389M 384M 382M 394M 403M 381.33M
Shares Outstanding (Diluted)
389M 384M 382M 416M 431M 381.33M
EPS (Basic)
-7.26 -9.27 -12.34 21.26 30.31 -1.96
EPS (Diluted)
-7.26 -9.27 -12.34 20.10 28.29 -1.96
EBITDA
-2.55B -3.39B -3.28B 9.95B 13.54B -703.38M
EBIT
-2.77B -3.58B -3.9B 9.6B 13.3B -734.63M
Depreciation & Amortization
215M 189M 621M 348M 232M 31.25M

© 2026 bestshares.com. All rights reserved.